Foundation and Clinical About the Expression of PD-1 in Peripheral Blood T Lymphocytes
NCT05792995
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
80
Enrollment
OTHER
Sponsor class
Conditions
Non-small Cell Lung Cancer
Interventions
DRUG:
Sindillimab
Sponsor
Xin-Hua Xu